Skip to main content Accessibility help
×
Home

Antidepressants in paediatric depression: do not look back in anger but around in awareness

  • David A. Brent (a1) (a2), Robert D. Gibbons (a3), Paul Wilkinson (a4) (a5) and Bernadka Dubicka (a6) (a7)

Abstract

Summary

In this paper, we summarise and critique a network meta-analysis (NMA) of antidepressant efficacy and tolerability for paediatric depression and an accompanying editorial. Although we agree that many of the extant studies are flawed, this meta-analysis showed clear efficacy of fluoxetine in the NMA, and for sertraline and escitalopram in pairwise analyses. Consequently, these papers underestimate the benefits of antidepressants for paediatric depression, and provide support for current practice guideline, which recommends the use of an antidepressant if the patient does not respond to psychotherapy. In these circumstances, fluoxetine should be the first choice, with escitalopram and sertraline as alternatives.

Declaration of interest

D.A.B. receives royalties from Guilford Press, has or will receive royalties from the electronic self-rated version of the C-SSRS from eResearch Technology, Inc., is on the editorial board of UpToDate, and is a reviewer for Healthwise. R.D.G. serves as an expert witness for the US Department of Justice, Pfizer, Wyeth and GSK; and is the founder of Adaptive Testing Technologies. P.W. receives personal fees from Lundbeck and Takeda. B.D. reports a licensing agreement with Lundbeck for a psychosocial treatment manual for depression. No other disclosures were reported.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Antidepressants in paediatric depression: do not look back in anger but around in awareness
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Antidepressants in paediatric depression: do not look back in anger but around in awareness
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Antidepressants in paediatric depression: do not look back in anger but around in awareness
      Available formats
      ×

Copyright

This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.

Corresponding author

Correspondence to David A. Brent (brentda@upmc.edu)

References

Hide All
1 Cipriani, A, Zhou, X, Del Giovane, C, Hetrick, SE, Qin, B, Whittington, C, et al. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: A network meta-analysis. Lancet 2016; 388(10047): 881–90.
2 Jureidini, J. Antidepressants fail, but no cause for therapeutic gloom. Lancet 2016; 388(10047): 844–5.
3 Weisz, JR, Kuppens, S, Ng, MY, Eckshtain, D, Ugueto, AM, Vaughn-Coaxum, R, et al. What five decades of research tells us about the effects of youth psychological therapy: A multilevel meta-analysis and implications for science and practice. Am Psychol 2017; 72(2): 79117.
4 March, J, Silva, S, Petrycki, S, Curry, J, Wells, K, Fairbank, J, et al. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depression Study (TADS) randomized controlled trial. JAMA 2004; 292(7): 807–20.
5 Bridge, JA, Iyengar, S, Salary, CB, Barbe, RP, Birmaher, B, Pincus, HA, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: A meta-analysis of randomized controlled trials. JAMA 2007; 297(15): 1683–96.
6 Bridge, JA, Birmaher, B, Iyengar, S, Barbe, RP, Brent, DA. Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder. Am J Psychiatry 2009; 166(1): 42–9.
7 Furukawa, TA, Cipriani, A, Atkinson, LZ, Leucht, S, Ogawa, Y, Takeshima, N, et al. Placebo response rates in antidepressant trials: A systematic review of published and unpublished double-blind randomised controlled studies. Lancet Psychiatry 2016; 3(11): 1059–66.
8 Leucht, S, Leucht, C, Huhn, M, Chaimani, A, Mavridis, D, Helfer, B, et al. Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: systematic review, Bayesian meta-analysis, and meta-regression of efficacy predictors. Am J Psychiatry 2017; 174(10): 927–42.
9 Gibbons, RD, Hur, K, Brown, CH, Davis, JM, Mann, JJ. Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine. Arch Gen Psychiatry 2012; 69(6): 572–9.
10 Hazell, P, O'Connell, D, Heathcote, D, Robertson, J, Henry, D. Efficacy of tricyclic drugs in treating child and adolescent depression: A meta-analysis. BMJ 1995; 310(6984): 897901.
11 Brent, DA, Emslie, GJ, Clarke, GN, Asarnow, J, Spirito, A, Ritz, L, et al. Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study. Am J Psychiatry 2009; 166(4): 418–26.
12 Atkinson, SD, Prakash, A, Zhang, Q, Pangallo, BA, Bangs, ME, Emslie, GJ, et al. A double-blind efficacy and safety study of duloxetine flexible dosing in children and adolescents with major depressive disorder. J Child Adolesc Psychopharmacol 2014; 24(4): 180–9.
13 Simon, GE, Savarino, J. Suicide attempts among patients starting depression treatment with medications or psychotherapy. Am J Psychiatry 2007; 164(7): 1029–34.
14 Gibbons, RD, Hur, K, Bhaumik, DK, Mann, JJ. The relationship between antidepressant prescription rates and rate of early adolescent suicide. Am J Psychiatry 2006; 163(11): 1898–904.
15 Gibbons, RD, Hur, K, Bhaumik, DK, Mann, JJ. The relationship between antidepressant medication use and rate of suicide. Arch Gen Psychiatry 2005; 62(2): 165–72.
16 Ludwig, J, Marcotte, DE, Norberg, K. Anti-depressants and suicide. J Health Econ 2009; 28(3): 659–76.
17 Gibbons, RD, Brown, CH, Hur, K, Marcus, SM, Bhaumik, DK, Erkens, JA, et al. Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry 2007; 164(9): 1356–63.
18 Katz, LY, Kozyrskyj, AL, Prior, HJ, Enns, MW, Cox, BJ, Sareen, J. Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults. CMAJ 2008; 178(8): 1005–11.
19 Vitiello, B, Rohde, P, Silva, S, Wells, K, Casat, C, Waslick, B, et al. Functioning and quality of life in the Treatment for Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry 2006; 45(12): 1419–26.
20 Emslie, G, Kratochvil, C, Vitiello, B, Silva, S, Mayes, T, McNulty, S, et al. Treatment for Adolescents with Depression Study (TADS): Safety results. J Am Acad Child Adolesc Psychiatry 2006; 45(12): 1440–55.
21 March, JS, Silva, S, Petrycki, S, Curry, J, Wells, K, Fairbank, J, et al. The Treatment for Adolescents With Depression Study (TADS): Long-term effectiveness and safety outcomes. Arch Gen Psychiatry 2007; 64(10): 1132–43.
22 Brent, DA, Holder, D, Kolko, D, Birmaher, B, Baugher, M, Roth, C, et al. A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy. Arch Gen Psychiatry 1997; 54(9): 877–85.
23 Hopkins, K, Crosland, P, Elliott, N, Bewley, S. Diagnosis and management of depression in children and young people: Summary of updated NICE guidance. BMJ 2015; 350: h824.
24 Brent, D, Emslie, G, Clarke, G, Wagner, KD, Asarnow, JR, Keller, M, et al. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: The TORDIA randomized controlled trial. JAMA 2008; 299(8): 901–13.
25 Curry, J, Rohde, P, Simons, A, Silva, S, Vitiello, B, Kratochvil, C, et al. Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry 2006; 45(12): 1427–39.
26 Vitiello, B, Emslie, G, Clarke, G, Wagner, KD, Asarnow, JR, Keller, MB, et al. Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: A follow-up study of the TORDIA sample. J Clin Psychiatry 2011; 72(3): 388–96.
27 Walkup, JT. Antidepressant efficacy for depression in children and adolescents: Industry- and NIMH-funded studies. Am J Psychiatry 2017; 174(5): 430–7.
28 Thurber, J. Lanterns & Lances: New York: Harper; 1961: xv.

Antidepressants in paediatric depression: do not look back in anger but around in awareness

  • David A. Brent (a1) (a2), Robert D. Gibbons (a3), Paul Wilkinson (a4) (a5) and Bernadka Dubicka (a6) (a7)

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Antidepressants in paediatric depression: do not look back in anger but around in awareness

  • David A. Brent (a1) (a2), Robert D. Gibbons (a3), Paul Wilkinson (a4) (a5) and Bernadka Dubicka (a6) (a7)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *